Ensoma website screenshot

Ensoma

Ensoma is a privately held, clinical-stage genomic medicines company developing in vivo hematopoietic stem cell (HSC) engineering. Its platform pairs an off-the-shelf in vivo delivery system built on high-capacity virus-like particles that preferentially bind HSCs with a gene engineering toolkit spanning base editing and high-efficiency gene integration, carrying payloads of roughly 35 kilobases so that changes from single-base edits through multi-gene insertions can be made without ex vivo cell collection, manipulation, or transplant conditioning. The company is pursuing programs across genetic disease, immune disorders, and oncology, including EN-374 for X-linked chronic granulomatous disease, and is backed by 5AM Ventures, F-Prime Capital, RTW Investments, Alexandria Venture Investments, Cormorant Asset Management, and the Bill & Melinda Gates Foundation. Enrichment found no public developer API, developer portal, SDK, OpenAPI/GraphQL/AsyncAPI contract, MCP server, or agent card — this is a therapeutics R&D company, not an API provider. Its only public machine-readable output is open-source computational genomics and sequencing-pipeline code published under its GitHub organization.

Ensoma is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Genomic Medicine, Gene Therapy, and Cell Therapy.

Ensoma’s developer surface includes product news and 13 more developer resources.

11.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyGenomic MedicineGene TherapyCell TherapyLife SciencesHealthcareBioinformaticsPrivate Company

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 11.7/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.6 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/ensoma: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Ensoma Domain Security

TLSv1.3

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 3

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: ensoma
name: Ensoma
description: Ensoma is a privately held, clinical-stage genomic medicines company developing in vivo hematopoietic stem cell
  (HSC) engineering. Its platform pairs an off-the-shelf in vivo delivery system built on high-capacity virus-like particles
  that preferentially bind HSCs with a gene engineering toolkit spanning base editing and high-efficiency gene integration,
  carrying payloads of roughly 35 kilobases so that changes from single-base edits through multi-gene insertions can be made
  without ex vivo cell collection, manipulation, or transplant conditioning. The company is pursuing programs across genetic
  disease, immune disorders, and oncology, including EN-374 for X-linked chronic granulomatous disease, and is backed by 5AM
  Ventures, F-Prime Capital, RTW Investments, Alexandria Venture Investments, Cormorant Asset Management, and the Bill & Melinda
  Gates Foundation. Enrichment found no public developer API, developer portal, SDK, OpenAPI/GraphQL/AsyncAPI contract, MCP
  server, or agent card — this is a therapeutics R&D company, not an API provider. Its only public machine-readable output
  is open-source computational genomics and sequencing-pipeline code published under its GitHub organization.
image: https://ensoma.com/wp-content/uploads/2021/02/ENS-Logomark-Final-color-341x341.png
url: https://raw.githubusercontent.com/api-evangelist/ensoma/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
x-no-api-surface: true
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Biotechnology
- Genomic Medicine
- Gene Therapy
- Cell Therapy
- Life Sciences
- Healthcare
- Bioinformatics
- Private Company
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://ensoma.com/
- type: About
  url: https://ensoma.com/inside-ensoma/
- type: Science
  url: https://ensoma.com/our-science/
- type: Pipeline
  url: https://ensoma.com/pipeline/
- type: News
  url: https://ensoma.com/news/
- type: Careers
  url: https://ensoma.com/careers/
- type: Contact
  url: https://ensoma.com/contact/
- type: TermsOfService
  url: https://ensoma.com/terms-of-use/
- type: PrivacyPolicy
  url: https://ensoma.com/privacy-policy/
- type: GitHubOrganization
  url: https://github.com/ensoma
- type: LinkedIn
  url: https://www.linkedin.com/company/ensomabio
- type: SecondaryMarket
  url: https://forgeglobal.com/ensoma_stock/
- type: LLMsTxt
  url: llms/ensoma-llms.txt
- type: DomainSecurity
  url: security/ensoma-domain-security.yml
x-contract-discovery:
  date: '2026-08-04'
  method: probed
  result: no-machine-readable-contract
  hosts_probed:
  - ensoma.com
  notes: api.ensoma.com does not resolve (NXDOMAIN); no baseURL or OpenAPI servers[] host exists to probe. ensoma.com is a
    WordPress marketing site.
  probes:
  - url: https://ensoma.com/openapi.json
    status: 404
  - url: https://ensoma.com/openapi.yaml
    status: 404
  - url: https://ensoma.com/swagger.json
    status: 404
  - url: https://ensoma.com/v1/openapi.json
    status: 404
  - url: https://ensoma.com/api-docs
    status: 404
  - url: https://ensoma.com/docs
    status: 404
  - url: https://ensoma.com/redoc
    status: 404
  - url: https://ensoma.com/llms.txt
    status: 404
  - url: https://ensoma.com/.well-known/security.txt
    status: 404
  - url: https://ensoma.com/.well-known/openid-configuration
    status: 404
  - url: https://ensoma.com/.well-known/oauth-authorization-server
    status: 404
  - url: https://ensoma.com/.well-known/api-catalog
    status: 404
  - url: https://ensoma.com/.well-known/ai-plugin.json
    status: 404
  - url: https://ensoma.com/.well-known/agent-card.json
    status: 404
  - url: https://ensoma.com/.well-known/agent.json
    status: 404
  observed:
  - url: https://ensoma.com/wp-json/
    status: 200
    note: Default WordPress REST API on the marketing CMS. Not a product API, not documented, and not offered to developers
      — recorded for provenance only, deliberately NOT catalogued as an API.
  registries_probed:
  - registry: npm
    query: ensoma
    result: none
  - registry: npm
    query: '@ensoma/sdk'
    result: none
  - registry: pypi
    query: ensoma
    result: unrelated third-party package (taskwarrior sync tool) — not first-party
  - registry: rubygems
    query: ensoma
    result: none
  - registry: packagist
    query: ensoma/ensoma
    result: none
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 2
  pass: local-v1